Literature DB >> 17189700

Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.

Karine Merienne1, James Friedman, Masayuki Akimoto, Gretta Abou-Sleymane, Chantal Weber, Anand Swaroop, Yvon Trottier.   

Abstract

We have approached the role of cellular stress in neurodegenerative diseases caused by polyglutamine expansion (polyQ) in the context of Spinocerebellar ataxia type 7 (SCA7) that includes retinal degeneration. Using the R7E mouse, in which polyQ-ataxin-7 is specifically over-expressed in rod photoreceptors, we previously showed that rod dysfunction correlated to moderate and prolonged activation of the JNK/c-Jun stress pathway. SCA7 retinopathy was also associated with reduced expression of rod-specific genes, including the transcription factor Nrl, which is essential for rod differentiation and function. Here, we report that R7E retinopathy is improved upon breeding with the JunAA knock-in mice, in which JNK-mediated activation of c-Jun is compromised. Expression of Nrl and its downstream targets, which are involved in phototranduction, are partially restored in the JunAA-R7E mice. We further show that c-Jun can directly repress the transcription of Nrl. Our studies suggest that polyQ-induced cellular stress leads to repression of genes necessary for neuronal fate and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189700      PMCID: PMC1858671          DOI: 10.1016/j.nbd.2006.11.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  68 in total

1.  Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release.

Authors:  J Whitfield; S J Neame; L Paquet; O Bernard; J Ham
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

Review 2.  Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

Authors:  M Y Sherman; A L Goldberg
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

3.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

4.  Nrl and Sp nuclear proteins mediate transcription of rod-specific cGMP-phosphodiesterase beta-subunit gene: involvement of multiple response elements.

Authors:  L E Lerner; Y E Gribanova; M Ji; B E Knox; D B Farber
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

5.  Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function.

Authors:  Koji M Nishiguchi; James S Friedman; Michael A Sandberg; Anand Swaroop; Eliot L Berson; Thaddeus P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

Review 6.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

7.  AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.

Authors:  C Grimm; A Wenzel; A Behrens; F Hafezi; E F Wagner; C E Remé
Journal:  Cell Death Differ       Date:  2001-08       Impact factor: 15.828

8.  STAT3 activation in response to growth factors or cytokines participates in retina precursor proliferation.

Authors:  Samuel Shao-Min Zhang; Mu-Gen Liu; Arihiro Kano; Chun Zhang; Xin-Yuan Fu; Colin J Barnstable
Journal:  Exp Eye Res       Date:  2005-07       Impact factor: 3.467

9.  YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter.

Authors:  L M Alvarez-Salas; M L Benitez-Hess; J A Dipaolo
Journal:  Int J Oncol       Date:  2005-01       Impact factor: 5.650

10.  Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.

Authors:  Dominique Helmlinger; Jacques Bonnet; Jean-Louis Mandel; Yvon Trottier; Didier Devys
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

View more
  6 in total

1.  Effect of brain-derived neurotrophic factor on c-jun expression in the rd mouse retina.

Authors:  Rui Chen; Xiao-Bei Yin; Chun-Xia Peng; Gen-Lin Li
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 2.  Genetically engineered mouse models of the trinucleotide-repeat spinocerebellar ataxias.

Authors:  Melissa A C Ingram; Harry T Orr; H Brent Clark
Journal:  Brain Res Bull       Date:  2011-07-23       Impact factor: 4.077

Review 3.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases.

Authors:  Laszlo Mester; Aliz Szabo; Tamas Atlasz; Krisztina Szabadfi; Dora Reglodi; Peter Kiss; Boglarka Racz; Andrea Tamas; Ferenc Gallyas; Balazs Sumegi; Eniko Hocsak; Robert Gabriel; Krisztina Kovacs
Journal:  Neurotox Res       Date:  2009-04-09       Impact factor: 3.911

Review 5.  Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.

Authors:  Pawel M Switonski; Wojciech J Szlachcic; Agnieszka Gabka; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2012-09-04       Impact factor: 5.590

6.  Transcriptional activation of REST by Sp1 in Huntington's disease models.

Authors:  Myriam Ravache; Chantal Weber; Karine Mérienne; Yvon Trottier
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.